A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC
Clinical trial NCT06422546 · UNKNOWN
Trial details
- NCT number
- NCT06422546
- Sponsor
- Beijing Cancer Prevention & Treatment Society
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-15
- Primary completion
- 2024-07-31
- Enrollment
- 950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.